Chemed Co. (NYSE:CHE) Stock Holdings Lowered by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC lowered its position in shares of Chemed Co. (NYSE:CHE) by 9.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 184,210 shares of the company’s stock after selling 19,300 shares during the period. Chemed comprises about 1.6% of TimesSquare Capital Management LLC’s investment portfolio, making the stock its 8th biggest holding. TimesSquare Capital Management LLC’s holdings in Chemed were worth $107,717,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CHE. GAMMA Investing LLC purchased a new stake in Chemed in the 4th quarter worth approximately $37,000. Larson Financial Group LLC bought a new stake in Chemed in the third quarter valued at $44,000. SRS Capital Advisors Inc. raised its holdings in Chemed by 110.6% in the 4th quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after purchasing an additional 52 shares in the last quarter. Covestor Ltd boosted its stake in shares of Chemed by 27.4% during the 3rd quarter. Covestor Ltd now owns 144 shares of the company’s stock valued at $75,000 after purchasing an additional 31 shares in the last quarter. Finally, ORG Partners LLC purchased a new stake in Chemed during the 3rd quarter worth approximately $126,000. Institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the transaction, the vice president now owns 1,422 shares of the company’s stock, valued at $917,190. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the sale, the vice president now directly owns 1,422 shares in the company, valued at approximately $917,190. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares in the company, valued at $13,320,654. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,808 shares of company stock valued at $10,184,531. 3.32% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CHE has been the subject of several research analyst reports. Oppenheimer raised their price objective on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Thursday, February 29th. Royal Bank of Canada lifted their price objective on shares of Chemed from $604.00 to $712.00 and gave the company an “outperform” rating in a research note on Monday, March 4th. Finally, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th.

Chemed Price Performance

CHE stock traded up $1.42 during trading on Thursday, hitting $574.13. 96,395 shares of the company traded hands, compared to its average volume of 81,448. The company has a market cap of $8.69 billion, a PE ratio of 30.80, a P/E/G ratio of 2.29 and a beta of 0.46. Chemed Co. has a 1 year low of $492.84 and a 1 year high of $654.62. The stock’s 50-day simple moving average is $618.69 and its 200 day simple moving average is $594.39.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The firm had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Research analysts expect that Chemed Co. will post 21.72 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.28%. Chemed’s dividend payout ratio is currently 8.61%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.